Terry Roemer

8.1k total citations · 1 hit paper
56 papers, 4.6k citations indexed

About

Terry Roemer is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Terry Roemer has authored 56 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 28 papers in Infectious Diseases and 17 papers in Pharmacology. Recurrent topics in Terry Roemer's work include Antifungal resistance and susceptibility (17 papers), Fungal and yeast genetics research (17 papers) and Microbial Natural Products and Biosynthesis (14 papers). Terry Roemer is often cited by papers focused on Antifungal resistance and susceptibility (17 papers), Fungal and yeast genetics research (17 papers) and Microbial Natural Products and Biosynthesis (14 papers). Terry Roemer collaborates with scholars based in United States, Canada and Spain. Terry Roemer's co-authors include Damian J. Krysan, Howard Bussey, Bo Jiang, M Snyder, Charles Boone, Susan Sillaots, Troy Ketela, Deming Xu, John Davison and Sébastien Lemieux and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Terry Roemer

56 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches

2014 427 citations Terry Roemer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Terry Roemer United States	37	2.9k	1.6k	938	882	673	56	4.6k
Joachim F. Ernst Germany	40	2.6k 0.9×	2.7k 1.7×	1.8k 1.9×	761 0.9×	339 0.5×	86	4.5k
Haoping Liu United States	33	2.8k 1.0×	2.8k 1.7×	1.9k 2.0×	803 0.9×	367 0.5×	56	4.5k
Peter E. Sudbery United Kingdom	31	2.9k 1.0×	2.4k 1.5×	1.5k 1.6×	733 0.8×	279 0.4×	59	4.8k
Elaine Bignell United Kingdom	31	1.6k 0.6×	1.7k 1.0×	968 1.0×	1.4k 1.6×	729 1.1×	80	4.0k
Janet Quinn United Kingdom	35	2.6k 0.9×	1.4k 0.9×	962 1.0×	811 0.9×	276 0.4×	62	4.4k
Miguel C. Teixeira Portugal	39	3.2k 1.1×	1.1k 0.7×	742 0.8×	1.2k 1.3×	240 0.4×	100	5.1k
Geraldine Butler Ireland	45	3.0k 1.0×	2.8k 1.7×	2.0k 2.1×	1.1k 1.3×	390 0.6×	124	5.5k
H. Vanden Bossche Belgium	39	1.1k 0.4×	2.0k 1.3×	1.6k 1.7×	558 0.6×	597 0.9×	65	4.2k
Piet W. J. de Groot Netherlands	34	2.2k 0.8×	2.3k 1.4×	1.5k 1.6×	1.4k 1.6×	501 0.7×	74	4.6k
Rafael Sentandreu Spain	38	2.5k 0.9×	1.7k 1.1×	858 0.9×	1.6k 1.8×	328 0.5×	158	4.4k

Countries citing papers authored by Terry Roemer

Since Specialization

Citations

This map shows the geographic impact of Terry Roemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Roemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Roemer more than expected).

Fields of papers citing papers by Terry Roemer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Roemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Roemer. The network helps show where Terry Roemer may publish in the future.

Co-authorship network of co-authors of Terry Roemer

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Roemer. A scholar is included among the top collaborators of Terry Roemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Roemer. Terry Roemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balibar, Carl J., Artjohn Villafania, Christopher M. Barbieri, et al.. (2018). Validation and Development of an Escherichia coli Riboflavin Pathway Phenotypic Screen Hit as a Small-Molecule Ligand of the Flavin Mononucleotide Riboswitch. Methods in molecular biology. 1787. 19–40. 6 indexed citations

Wang, Hao, Paul A. Mann, Li Xiao, et al.. (2017). Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting. Cell chemical biology. 24(5). 576–588.e6. 72 indexed citations

Labroli, Marc, John P. Caldwell, Christine Yang, et al.. (2016). Discovery of potent wall teichoic acid early stage inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(16). 3999–4002. 9 indexed citations

Hou, Yan, Todd Mayhood, Payal R. Sheth, et al.. (2016). NMR Binding and Functional Assays for Detecting Inhibitors of S. aureus MnaA. SLAS DISCOVERY. 21(6). 579–589. 3 indexed citations

O’Meara, Teresa R., Amanda O. Veri, Troy Ketela, et al.. (2015). Global analysis of fungal morphology exposes mechanisms of host cell escape. Nature Communications. 6(1). 6741–6741. 183 indexed citations

Roemer, Terry & Charles Boone. (2013). Systems-level antimicrobial drug and drug synergy discovery. Nature Chemical Biology. 9(4). 222–231. 111 indexed citations

Roemer, Terry, Tanja Schneider, & Mariana G. Pinho. (2013). Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics. Current Opinion in Microbiology. 16(5). 538–548. 50 indexed citations

Münch, Daniela, Terry Roemer, Sang Ho Lee, et al.. (2012). Identification and in vitro Analysis of the GatD/MurT Enzyme-Complex Catalyzing Lipid II Amidation in Staphylococcus aureus. PLoS Pathogens. 8(1). e1002509–e1002509. 77 indexed citations

Meredith, Timothy C., Hao Wang, Patrick Beaulieu, Angelika Gründling, & Terry Roemer. (2012). Harnessing the power of transposon mutagenesis for antibacterial target identification and evaluation. Mobile Genetic Elements. 2(4). 171–178. 16 indexed citations

10.

Roemer, Terry, Deming Xu, Sheo B. Singh, et al.. (2011). Confronting the Challenges of Natural Product-Based Antifungal Discovery. Chemistry & Biology. 18(2). 148–164. 118 indexed citations

11.

Wallace, Iain M., Malene L. Urbanus, Genna M. Luciani, et al.. (2011). Compound Prioritization Methods Increase Rates of Chemical Probe Discovery in Model Organisms. Chemistry & Biology. 18(10). 1273–1283. 38 indexed citations

12.

Becker, Jeffrey M., Sarah Kauffman, Melinda Hauser, et al.. (2010). Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model. Proceedings of the National Academy of Sciences. 107(51). 22044–22049. 107 indexed citations

13.

Huber, Joann, Robert G. K. Donald, Sang Ho Lee, et al.. (2009). Chemical Genetic Identification of Peptidoglycan Inhibitors Potentiating Carbapenem Activity against Methicillin-Resistant Staphylococcus aureus. Chemistry & Biology. 16(8). 837–848. 75 indexed citations

14.

Bills, Gerald F., Gonzalo Platas, David P. Overy, et al.. (2009). Discovery of the parnafungins, antifungal metabolites that inhibit mRNA polyadenylation, from theFusarium larvarumcomplex and other Hypocrealean fungi. Mycologia. 101(4). 449–472. 46 indexed citations

15.

Hogues, Hervé, Hugo Lavoie, Adnane Sellam, et al.. (2008). Transcription Factor Substitution during the Evolution of Fungal Ribosome Regulation. Molecular Cell. 29(5). 552–562. 93 indexed citations

16.

Herath, Kithsiri, Guy H. Harris, Hiranthi Jayasuriya, et al.. (2008). Isolation, structure and biological activity of phomafungin, a cyclic lipodepsipeptide from a widespread tropical Phoma sp.. Bioorganic & Medicinal Chemistry. 17(3). 1361–1369. 33 indexed citations

17.

Overy, David P., Jennifer Nielsen Kahn, Ming‐Jo Hsu, et al.. (2008). Isolation and structure elucidation of parnafungins C and D, isoxazolidinone-containing antifungal natural products. Bioorganic & Medicinal Chemistry Letters. 19(4). 1224–1227. 24 indexed citations

18.

Xu, Deming, Bo Jiang, Troy Ketela, et al.. (2007). Genome-Wide Fitness Test and Mechanism-of-Action Studies of Inhibitory Compounds in Candida albicans. PLoS Pathogens. 3(6). e92–e92. 189 indexed citations

19.

Roemer, Terry, Bo Jiang, John Davison, et al.. (2003). Large‐scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Molecular Microbiology. 50(1). 167–181. 385 indexed citations

20.

Roemer, Terry, Nathalie Fortin, & Howard Bussey. (1994). XVI. Yeast sequencing reports. DNA sequence analysis of a 10·4 kbp region on the right arm of yeast chromosome XVI positions GPH1 and SGV1 adjacent to KRE6, and identifies two novel tRNA genes. Yeast. 10(11). 1527–1530. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact